US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Redeye: Doro - Total Rebuild

Redeye raises short-term earnings estimates, following Doro’s major restructuring program. However, the worsened growth prospects in Phones make us turn down our rating, meaning a higher required rate of return. All in all, we maintain our fair value range. Read more and download the research update: https://bit.ly/2BJ9Rag Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

Redeye: Doro - Segment Reporting Highlights Value

Redeye continues to see very attractive risk/reward in the Doro stock. The company will be temporarily hit by the Corona crisis, but the balance sheet is strong. From 2021, we expect shares to be driven by an increased focus on the brand-new segment reporting that highlights the value of the Care segment. Read more and download the research update: https://bit.ly/3eW1Cqk   Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/

Redeye: Doro - Same ol’ situation in phones … but Care is appealing

The previous trends for Doro with stronger EBIT and negative underlying sales growth continued in Q3. We have lately become a lot more optimistic towards the future market prospects for Care, most notably related to the GreatCall bid. However, we see a risk that the traditional phones business could continue to weigh on the total.Read more in our new research update: http://bit.ly/2J81OmJ Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.

Redeye: Doro - Continuing convalescence

We have updated our research of Doro following the company's Q2 report. Overall, the Q2 earnings release followed the same trends as the previous quarters and we have therefore not changed our thinking with regards to our view of the Doro case.Read more in the Research Update by Viktor Westman at: https://goo.gl/P3ixY7  Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/

Redeye - Expansion and increased sales for Doro

Doro’s Q1 EBIT loss of SEK -22.5 million was SEK 12.2 million worse than our expectations, although the sales of SEK 340.1 million, meaning a sales growth of 46 percent was in line with our prognosis. Especially Doro’s EMEA sales growth of 78.1 percent stood out as encouraging on this supposedly most mature of Doro’s markets. We believe there is a lot more to come in the newer EMEA markets. In particular, we like the expansion of the Vodafone partnership. As late as today Doro announced that the Company will enter Romania together with Vodafone. As we previously mentioned, we believe that

Redeye - Currency stifled solid report from Doro

Doro’s sales amounted to SEK 437 million, following a growth of 15 percent; 3 percentage points better than our estimates. EBIT at SEK 37.8 million, however, was SEK 10 million lower than expected due to marketing campaigns. Sales and order intake were strong in all major regions and smartphone sales in Europe grew sequentially from 10 to 15 percent of total sales. The outlook for H1 (regarding currency effects) concerned the market. Doro’s CEO’s sound concern and call for action on this matter had the opposite effect. Our investment case, however, remains intact, meaning that we

Redeye - Doro can boast with strong Q3-numbers

The revenue in Q3 widely exceeded our estimates of SEK 291 million, coming in at SEK 330 million. As a result EBIT amounted to SEK 29 million, instead of our estimates of SEK 19 million. We expected continuing weak sales in the Nordics and in North America, but sales in all markets grew more than expected. The order intake was even stronger than sales and came in at SEK 424 million. This represents a 16 percent annual growth and is due to the new listings from e.g. Vodafone and Telekom Deutschland. Following the strong Q3, we have raised our sales estimates for Q4 and 2015.  Our new fair

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe